Stay updated on Efficacy of CT-P43 vs Stelara in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of CT-P43 vs Stelara in Plaque Psoriasis Clinical Trial page.

Latest updates to the Efficacy of CT-P43 vs Stelara in Plaque Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record provides details for a completed Phase 3 comparison of CT-P43 and Stelara for moderate to severe plaque psoriasis, including participant criteria, study measures, and a study location in Estonia. It also includes results-related dates, a linked publication, and study documents.SummaryDifference45%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedAn NIH-wide notice about terminology changes during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the record. This reflects a permission issue rather than a change to the study information.SummaryDifference18%

Stay in the know with updates to Efficacy of CT-P43 vs Stelara in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of CT-P43 vs Stelara in Plaque Psoriasis Clinical Trial page.